EC Number | Application | Comment | Organism |
---|---|---|---|
6.3.4.5 | medicine | argininosuccinate synthetase is inhibited by endotoxin, implying that bacterial products might potentially regulate the arginine metabolism in the host and perturb NO synthesis | Mus musculus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
6.3.4.5 | diphosphoryl lipid A (DPL) | DPL from Escherichia coli, inhibits argininosuccinate synthetase in a dose-dependent manner, concentration for half inhibition of argininosuccinate synthetase enzyme activity: 0.039 mg/ml | Mus musculus | |
6.3.4.5 | monophosphoryl lipid A (MPL) | MPL from Escherichia coli, inhibits argininosuccinate synthetase in a dose-dependent manner, concentration for half inhibition of argininosuccinate synthetase enzyme activity: 0.270 mg/ml | Mus musculus | |
6.3.4.5 | R-lipopolysaccharide (LPS) | rough-type LPS from Escherichia coli, inhibits argininosuccinate synthetase in a dose-dependent manner, concentration for half inhibition of argininosuccinate synthetase enzyme activity: 0.230 mg/ml | Mus musculus | |
6.3.4.5 | S-lipopolysaccharide (LPS) | smooth-type-LPS from Escherichia coli, inhibits argininosuccinate synthetase in a dose-dependent manner, concentration for half inhibition of argininosuccinate synthetase enzyme activity: 0.024 mg/ml | Mus musculus | |
6.3.4.5 | sodium 2-deoxy-2-(3S-(9-phenyl-nonanoyl-oxy) tetradecanoyl) amino-3-O-(9-phenyl-nonanoyl)-D-glucopyranose 4-sulfate | synthesized lipid A analog, inhibits argininosuccinate synthetase in a dose-dependent manner, concentration for half inhibition of argininosuccinate synthetase enzyme activity: 0.0065 mg/ml | Mus musculus |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
6.3.4.5 | Mg2+ | - |
Mus musculus |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
6.3.4.5 | 45000 | - |
SDS-PAGE | Mus musculus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
6.3.4.5 | Mus musculus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
6.3.4.5 | analysis by native gel electrophoresis shows that argininosuccinate synthetase can bind bacterial lipopolysaccharide and lipid A | Mus musculus |
6.3.4.5 | argininosuccinate synthetase is purified from mouse liver. Livers are excised from 20 male mice (C3H/He strain, age 7-8 weeks) and homogenized in 100 mM Tris-HCl (pH 7.5) containing 1 mM citrulline and 1 mM aspartic acid. Homogenate is centrifuged. After salting-out with (NH4)2SO4. The sample is subjected to anion-exchange chromatography on DE-52. Concentrated samples are loaded on a column of Sephacryl S-300 HR. The collected first peak fractions are dialyzed and subjected to anion-exchange chromatography on UNO S-1 | Mus musculus |
EC Number | Reaction | Comment | Organism | Reaction ID |
---|---|---|---|---|
6.3.4.5 | ATP + L-citrulline + L-aspartate = AMP + diphosphate + 2-(Nomega-L-arginino)succinate | it is found that argininosuccinate synthetase is the major lipid A-interacting protein in liver. Argininosuccinate synthetase also inhibits the biological activities of natural lipid A and rough-type lipopolysaccharide and but not smooth-type lipopolysaccharide. Argininosuccinate synthetase enzyme activity is inhibited by lipid A and rough-type lipopolysaccharide and smooth-type lipopolysaccharide. | Mus musculus |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
6.3.4.5 | liver | - |
Mus musculus | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
6.3.4.5 | 0.14 | - |
purification step: liver homogenate supernatant | Mus musculus |
6.3.4.5 | 0.27 | - |
purification step: 45-55% saturated ammonium sulfate precipitate | Mus musculus |
6.3.4.5 | 0.99 | - |
purification step: DE-52 fraction | Mus musculus |
6.3.4.5 | 1.39 | - |
purification step: S-300 fraction | Mus musculus |
6.3.4.5 | 5.16 | - |
purification step: UNO S-1 fraction | Mus musculus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.3.4.5 | ATP + L-citrulline + L-aspartate | - |
Mus musculus | AMP + diphosphate + L-argininosuccinate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
6.3.4.5 | Argininosuccinate synthetase | - |
Mus musculus |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
6.3.4.5 | 37 | - |
assay at | Mus musculus |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
6.3.4.5 | 7.5 | - |
assay at | Mus musculus |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
6.3.4.5 | additional information | - |
substrate: diphosphoryl lipid A, IC50: 0.039 mg/ml | Mus musculus | additional information | |
6.3.4.5 | additional information | - |
substrate: monophosphoryl lipid A, IC50: 0.270 mg/ml | Mus musculus | additional information | |
6.3.4.5 | additional information | - |
substrate: R-lipopolysaccharide, IC50: 0.230 mg/ml | Mus musculus | additional information | |
6.3.4.5 | additional information | - |
substrate: S-lipopolysaccharide, IC50: 0.024 mg/ml | Mus musculus | additional information | |
6.3.4.5 | additional information | - |
substrate: sodium 2-deoxy-2-(3S-(9-phenyl-nonanoyl-oxy) tetradecanoyl) amino-3-O-(p-phenyl-nonanoyl)-D-glucopyranose 4-sulfate (ONO-4007), IC50: 0.0065 mg/ml | Mus musculus | additional information |